Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2004 December;56(6) > Minerva Ginecologica 2004 December;56(6):539-46

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

  OVARIAN CANCER


Minerva Ginecologica 2004 December;56(6):539-46

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Chemotherapy for ovarian cancer: an evidence-based approach

Geisler J. P., Manahan K. J., Wiemann M. C.


PDF  


Although cytoreductive surgery is the most influential factor in treatment for ovarian cancer, chemotherapy is needed for almost all patients diagnosed with this disease. The mainstay of chemotherapy is platinum. Different platinum compounds are used for different histologies, and different combinations are used for different histologies also. We will present the data so that each reader can understand the knowledge behind chemotherapy decisions.

top of page

Publication History

Cite this article as

Corresponding author e-mail